![](/i/left-body.webp)
PDFICD-O-3 SEER Site/Histology Validation List
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 1 April 29, 2022 ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST This file is intended as a reference file for ICD-O-3 only ...
https://seer.cancer.gov/icd-o-3/sitetype.icdo3.20220429.pdf - 679K
Preliminary Cancer Incidence Rates and Trends: Validation - SEER...
Validation Preliminary Cancer Incidence Rates and Trends: Validation Predicted Trends from Early Data Adjusted for Case Undercounts, SEER 18 Registries The most recent preliminary ...
https://seer.cancer.gov/...iminary-estimates/validation.html - 115K
DOCX2024 Cancer PathCHART ICD-O-3 Site Morphology Validation List...
PathCHART ICD-O-3 Site Morphology Validation List v1.0 Release Notes (File Date 8/... The 2024 Cancer PathCHART ICD-O-3 Site Morphology Validation List (CPC SMVL), output ...
https://seer.cancer.gov/..._CPC_SMVL_v1.0_Release_Notes.docx - 41K
SEER ICD-O-3 Coding Materials
ICD-O-3 SEER Site/Histology Validation Lists The Site/Histology List is not intended to be used for case finding or to determine reportability. The ICD-O-3 Site/Type Validation ...
https://seer.cancer.gov/icd-o-3/ - 31K
Cancer PathCHART Search
PathCHART ICD-O-3 Site Morphology Validation List (CPC*SMVL) validity standards by ... included in the 2024 Cancer PathCHART ICD-O-3 Site Morphology Validation List (CPC*SMVL). ...
https://seer.cancer.gov/cancerpathchart/search/ - 35K
PDFSeptember 2019 Autocons/Validation Minutes
... IMS will revisit the data search criteria regarding HL7 data. 4 Source Record Validation ... WG defines critical edits for source validation, a process for handling abstracts with ...
https://seer.cancer.gov/...up/auto-cons-workgroup-201909.pdf - 64K
PDFSEER*DMS Auto-Consolidation and Validation Work Group Meeting...
in the SEER*DMS Auto-Consolidation and Validation Work Group (WG) call on April 5, 2022. ... Linda agreed to update the Auto Consolidation and Validation WG "Squish" issues with ...
https://seer.cancer.gov/...p/auto-cons-workgroup-2022-04.pdf - 213K
PDFSEER*DMS Auto-Consolidation and Validation Work Group Meeting...
in the SEER*DMS Auto-Consolidation and Validation Work Group (WG) call on July 19, 2022. ... Upcoming SEER*DMS Meetings The next Auto-Consolidation and Validation WG call is scheduled ...
https://seer.cancer.gov/...group/seer-autocons_7-19-22-1.pdf - 249K
Residual Tissue Repository (RTR) Program
Enables studies on rare cancers by drawing from multiple registries to increase statistical power. Allows validation studies on specimens from population-based registries. Allows ...
https://seer.cancer.gov/biospecimen/ - 39K
PDFErrata for ICD-O-3 Site/Type Validation List
7, 2021 Errata for ICD-O-3 Site/Type Validation List The ICD-O-3 Site/Type Validation program was modified to only allow for the site/histology/behavior combinations listed in this ...
https://seer.cancer.gov/icd-o-3/errata.sitetype.20210607.pdf - 171K
![](/i/right-body.webp)